High Net Worth Advisory Group LLC Organon & Co. Transaction History

High Net Worth Advisory Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$23.31 - $28.61 $7,948 - $9,756	-341 Reduced 84.62%	62 $1,000
Q3 2022 Oct 24, 2022	SELL	$23.4 - $34.25 $14,976 - $21,920	-640 Reduced 61.36%	403 $9,000
Q2 2022 Aug 10, 2022	BUY	$31.66 - $38.9 $9,972 - $12,253	315 Added 43.27%	1,043 $35,000
Q1 2022 May 13, 2022	BUY	$30.45 - $39.36 $1,218 - $1,574	40 Added 5.81%	728 $25,000
Q4 2021 Apr 27, 2022	BUY	$28.67 - $37.13 $19,724 - $25,545	688 New	688 $22,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of High Net Worth Advisory Group LLC, based on Form 13F filings with the SEC.

Stay updated on High Net Worth Advisory Group LLC with notifications on news.